000			02068 a2200565 4500
005			20250515104708.0
264		0	_c20080311
008			200803s 0 0 eng d
022			_a1528-4336
024	7		_a10.1310/hct0901-11 _2doi
040			_aNLM _beng _cNLM
100	1		_aDemeter, Lisa M
245	0	0	_aAssociation of efavirenz hypersusceptibility with virologic response in ACTG 368, a randomized trial of abacavir (ABC) in combination with efavirenz (EFV) and indinavir (IDV) in HIV-infected subjects with prior nucleoside analog experience. _h[electronic resource]
260			_bHIV clinical trials _c
300			_a11-25 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAlkynes
650	0	4	_aAnti-HIV Agents _xtherapeutic use
650	0	4	_aBenzoxazines _xtherapeutic use
650	0	4	_aCD4 Lymphocyte Count
650	0	4	_aCyclopropanes
650	0	4	_aDideoxynucleosides _xtherapeutic use
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Resistance, Viral
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aHIV Infections _xdrug therapy
650	0	4	_aHIV Protease Inhibitors _xtherapeutic use
650	0	4	_aHIV-1 _xdrug effects
650	0	4	_aHumans
650	0	4	_aIndinavir _xtherapeutic use
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aTreatment Outcome
700	1		_aDeGruttola, Victor
700	1		_aLustgarten, Stephanie
700	1		_aBettendorf, Daniel
700	1		_aFischl, Margaret
700	1		_aEshleman, Susan
700	1		_aSpreen, William
700	1		_aNguyen, Bach-Yen
700	1		_aKoval, Christine E
700	1		_aEron, Joseph J
700	1		_aHammer, Scott
700	1		_aSquires, Kathleen
773	0		_tHIV clinical trials _gvol. 9 _gno. 1 _gp. 11-25
856	4	0	_uhttps://doi.org/10.1310/hct0901-11 _zAvailable from publisher's website
999			_c17723432 _d17723432